Align Technology | ALGN - Vermögenswerte

Aktienkurs
157.25
Täglich Wechseln
-3.28 -2.04%
Monatlich
-15.01%
Jährlich
-16.49%
Q2 Prognose
165.29




Vermögenswerte Veränderung Datum
3M USD 35.44B 2.3B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bruker USD 6.13B 110.7M 2026-03
Cardinal Health USD 56.69B 1.39B 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Cooper Companies USD 12.42B 29.4M 2025-12
CVS Health USD 252.97B 564M 2026-03
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.23B 200M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Henry Schein USD 11.3B 89M 2026-03
Idexx Laboratories USD 3.39B 34.74M 2026-03
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Masimo USD 1.64B 56.2M 2026-03
McKesson USD 82.32B 1.87B 2026-03
Mettler Toledo International USD 3.67B 43.73M 2026-03
Revvity USD 12B 171.82M 2026-03
Solventum Corp USD 14.1B 197M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Veeva Systems USD 8.98B 882.19M 2025-12
Waters USD 24.53B 19.45B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03
Zoetis USD 15.15B 313M 2026-03